Clobetasol propionate 0·05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial

✍ Scribed by G.A. Vena; N. Cassano; V. D'Argento; M. Milani

• Book ID: 108668547
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 70 KB
• Volume: 154
• Category: Article
• ISSN: 0007-0963
• DOI: 10.1111/j.1365-2133.2005.06986.x